Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

JZ201911040938-B_deep

ABSTRACT: JZ201911040938-B_deep

TISSUE(S): ['gland']

SUBMITTER: Yifan Zhao

PROVIDER: OEX00010718 | NODE | 2023-02-22

REPOSITORIES: NODE

ACCESS DATA

Json Xml

Similar Datasets

L1000 Dataset -small molecule perturbagens- LINCS Trans-Center Project

Project description:Transcriptional profiles of cultured human breast and prostate cancer cell lines treated with small molecules: 6 cancer cell lines are treated with 6 small molecules, as a part of the LINCS Trans-Center Project. The expression level for 978 representative genes is measured.

2014-05-30 | LDS-1202 | LINCS

L1000 Dataset -small molecule, CRISPR perturbagens- LINCS Phase 2 (December 2015)

Project description:Transcriptional profiles of multiple cell and perturbation types: 23 cells are treated with 311 chemical perturbagens and CRISPR reagents. The expression level for 978 representative genes is measured.

2015-12-31 | LDS-1293 | LINCS

L1000 Dataset -small molecule perturbagens- LINCS Joint Project

Project description:Transcriptional profiles of cultured human breast cancer cell lines treated with small molecules: 5 cell lines are treated with 109 small molecules and the expression of 978 representative genes is measured, as a part of the LINCS Joint Project.

2014-05-30 | LDS-1203 | LINCS

Tyrosine Kinase Inhibitor-induced cardiotoxicity in hiPSC derived cardiomyocytes - pilot dataset (qPCR validation)

Project description: Not available

2018-03-20 | LDS-1517 | LINCS

L1000 Dataset -small molecule perturbagens- LINCS Phase 1

Project description:Transcriptional profiles of cultured human cancer cell lines treated with small molecules: Expression of 978 representative genes is measured in 39 cell lines perturbed by 13 thousands of small molecules.

2014-05-30 | LDS-1191 | LINCS

L1000 gene expression profiling assay - DOS small molecule perturbagens

Project description:Transcriptional profiles of U2 OS cell line treated with ~21 thousands of compounds from diversity-oriented-synthesis (DOS) library.

2014-05-30 | LDS-1194 | LINCS

iMN (Exp 2) - ALS, SMA and Control (unaffected) iMN cell lines differentiated from iPS cell lines using a long differentiation protocol - RNA-seq

Project description:Total RNA-Seq was carried out on rRNA depleted RNA obtained from motor neuron lines generated from subject induced pluripotent stem cell (iPSC) lines. The iPSC lines were derived from 4 ALS, 3 SMA and 3 Control (unaffected) individuals, in duplicate.

2017-05-01 | LDS-1398 | LINCS

diMN (Exp 3) - ALS and Control (unaffected) diMN cell lines differentiated from iPS cell lines using a short and direct differeintiation protocol - RNA-seq

Project description:Total RNA-Seq was carried out on rRNA depleted RNA obtained from motor neuron lines generated from subject induced pluripotent stem cell (iPSC) lines. The iPSC lines were derived from 11 ALS and 4 Control (unaffected) individuals, in duplicate.

2017-10-13 | LDS-1499 | LINCS

L1000 Dataset -small molecule, CRISPR perturbagens- LINCS Phase 2 (March 2017)

Project description:Transcriptional profiles of multiple cell and perturbation types: cells are treated with chemical perturbagens and CRISPR reagents. The expression level for 978 representative genes is measured.

2016-03-06 | LDS-1372 | LINCS

Tyrosine Kinase Inhibitor-induced cardiotoxicity in hiPSC derived cardiomyocytes - pilot dataset

Project description: Not available

2018-03-20 | LDS-1516 | LINCS